Migraine
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Unilateral migraine, male and female, between 18 and 60 years old;(2)Meet the diagnostic criteria of migraine without aura in the International Classification of Headache Disorders ICHD-3 developed by the International Headache Society (IHS) in 2018; (3)Headache attacks of moderate to severe severity (VAS score 4-9);(4)Experiencing acute migraine attacks;(5)Those who volunteered to participate and signed the informed consent form. Note: Patients who meet the above 5 items at the same time may be included in this study.
Exclusion criteria
Exclusion criteria: (1)Patients with bilateral or alternating unilateral migraine;(2) With a history of any trauma to the head, the concomitant headache of another type, or headache of unknown diagnosis;(3) There were serious primary diseases of cardiovascular and cerebrovascular, liver, kidney, hematopoietic system, and other organic diseases;(4) Combined with severe anxiety, depression, insomnia, and other mental diseases or intellectual disability, unable to cooperate with the questionnaire, or infection, bleeding disorders, allergies, skin diseases, etc;(5) Patients who have already taken analgesic medication;(6) Pregnant or breastfeeding patients;(7) Participating in other similar studies. (Note: Patients meeting any of the above criteria will be excluded)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analgesic efficiency at 10 minutes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Analgesic efficiency at1,2,4,6,8,10min;Visual analog scale score (VAS);Evaluation of compliance;Evaluation of blinded success or failure; | — |
Countries
China
Contacts
Yunnan University of Chinese Medicine